Czechia, Sept. 21 -- Czechia based AbbVie s.r.o. has secured contract from Institut klinicke a experimentalni mediciny for Immunosuppressive agents - Selective immunosuppressants - Janus kinase II inhibitors - Upadacitinib . The value of the contract is worth 70904303 CZK .
Published by HT Digital Content Services with permission from Pivotal Sources....